|
- 2019
Phosphatidic Acid Enters into the YAP/TAZ ArenaDOI: https://doi.org/10.1016/j.molmed.2018.11.002 Abstract: Reporting in Molecular Cell, Han et al. (2018;2:328–340) show that phosphatidic acid promotes YAP activity through a double-hit inhibition of the LATS kinases, suggesting a therapeutic opportunity for the treatment of YAP/TAZ-dependent cancers and opening new prospects on the connections between lipid signaling and YAP/TAZ biology
|